SynthesisFrontiers in pharmacology2026

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence.

Chengwen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.